- Report
- September 2024
- 382 Pages
Global
From €6797EUR$7,150USD£5,710GBP
- Report
- October 2024
- 195 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 174 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- June 2024
- 185 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 210 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- July 2024
- 153 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- February 2025
- 404 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 606 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- March 2025
- 409 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- March 2025
- 197 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 186 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 192 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- October 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- August 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- October 2024
- 176 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2023
- 159 Pages
Global
From €2353EUR$2,475USD£1,977GBP
€4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 135 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- October 2023
- 190 Pages
Global
From €4278EUR$4,500USD£3,594GBP

The diagnostics market encompasses various medical tools and services employed to detect and monitor diseases and conditions within the human body. The respiratory diagnostics sector specifically focuses on the identification and management of disorders related to the lungs and respiratory system, such as chronic obstructive pulmonary disease (COPD), asthma, lung cancer, tuberculosis, and other respiratory tract infections. Diagnostic techniques and devices used in this field include spirometry, peak flow meters, imaging tests like X-rays and CT scans, bronchoscopy, pulmonary function testing, and blood gas analysis. Advances in molecular diagnostics, point-of-care testing, and biomarker development further contribute to the sophistication and capability of respiratory diagnostics.
The market for respiratory diagnostics comprises a variety of companies, incorporating both established healthcare giants and specialized firms dedicated to respiratory health. Entities like Philips Healthcare, ResMed, GE Healthcare, and Medtronic are known for their diverse portfolios, which include diagnostic imaging and monitoring equipment. Other companies such as Thermo Fisher Scientific provide a broad range of diagnostic and research-based products. Furthermore, Quest Diagnostics and Laboratory Corporation of America Holdings are key players in the field of clinical laboratory services, offering diagnostic testing for respiratory ailments. These companies operate within a competitive and innovative segment of the market that continues to evolve with technological advancements and research findings. Show Less Read more